UK markets closed

Cardinal Health, Inc. (CAH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
105.13+0.50 (+0.48%)
As of 03:49PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 25.48B
Enterprise value 27.62B
Trailing P/E 46.30
Forward P/E 13.89
PEG ratio (5-yr expected) 0.31
Price/sales (ttm)0.12
Price/book (mrq)N/A
Enterprise value/revenue 0.13
Enterprise value/EBITDA 16.29

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 313.37%
S&P500 52-week change 326.24%
52-week high 3116.04
52-week low 385.12
50-day moving average 3100.66
200-day moving average 3101.68

Share statistics

Avg vol (3-month) 31.96M
Avg vol (10-day) 32.27M
Shares outstanding 5243.57M
Implied shares outstanding 6243.57M
Float 8242.39M
% held by insiders 10.58%
% held by institutions 191.42%
Shares short (15 May 2024) 48.05M
Short ratio (15 May 2024) 43.74
Short % of float (15 May 2024) 44.41%
Short % of shares outstanding (15 May 2024) 43.30%
Shares short (prior month 15 Apr 2024) 48.71M

Dividends & splits

Forward annual dividend rate 42.02
Forward annual dividend yield 41.93%
Trailing annual dividend rate 32.00
Trailing annual dividend yield 31.91%
5-year average dividend yield 43.20
Payout ratio 488.60%
Dividend date 315 Jul 2024
Ex-dividend date 401 Jul 2024
Last split factor 23:2
Last split date 323 Apr 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.25%
Operating margin (ttm)1.07%

Management effectiveness

Return on assets (ttm)2.92%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)220.57B
Revenue per share (ttm)891.20
Quarterly revenue growth (yoy)8.80%
Gross profit (ttm)N/A
EBITDA 2.78B
Net income avi to common (ttm)552M
Diluted EPS (ttm)2.26
Quarterly earnings growth (yoy)-25.20%

Balance sheet

Total cash (mrq)3.72B
Total cash per share (mrq)15.27
Total debt (mrq)5.85B
Total debt/equity (mrq)N/A
Current ratio (mrq)0.98
Book value per share (mrq)-13.38

Cash flow statement

Operating cash flow (ttm)2.54B
Levered free cash flow (ttm)1.67B